NCT04397380 (COVID3T) is a clinical trial of Thermography in Pyrexia, sponsored by NHS Greater Clyde and Glasgow.

Who is sponsoring NCT04397380?

NCT04397380 is sponsored by NHS Greater Clyde and Glasgow.

What drugs are being tested in NCT04397380?

Interventions in NCT04397380: Thermography, Tympanic Temperature.

What condition does NCT04397380 study?

NCT04397380 studies Pyrexia, COVID.

Is NCT04397380 still recruiting?

NCT04397380 is currently status unknown. Last updated 22 May 2020.

Last reviewed 2020-05-22 · How we verify

NCT04397380: COVID3T

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study

Status unknown Last updated 22 May 2020

What this trial tests

trial testing Thermography in Pyrexia in 100 participants. Status unknown.

Timeline

20 May 2020

Primary endpoint
3 June 2020

1 July 2020

Quick facts

Lead sponsor	NHS Greater Clyde and Glasgow
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	20 May 2020
Primary completion	3 June 2020
Estimated completion	1 July 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Thermography
Tympanic Temperature

Conditions studied

Pyrexia — all drugs for Pyrexia →
COVID — all drugs for COVID →

Sponsor

NHS Greater Clyde and Glasgow

Who can join

16 and older, any sex, with Pyrexia or COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will refine and pilot the feasibility of introducing a thermal imaging test to detect fever in 100 patients being triaged within the Emergency Department. The only additional research requirement for the patient is to have a thermal image of their face taken. Other triage tests will be routine. The aims of the feasibility study are to: * Understand the acceptability of introducing the intervention within the Emergency Department setting * Establish indicative patient recruitment numbers per week * Determine the likely proportion of patients recruited from this group who have a high temperature * Provide preliminary evidence that the technology can identify a high temperature in this diverse group of patients * Provide preliminary data for machine learning training to support classification of patients as being with or without fever The feasibility study will then inform the design and size of larger study to further develop and validate the the thermal imaging screening test to provide a 'with/ without' fever result.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Thermography

Trials testing the same drug.

NCT04013711 — Thermal Imaging to Evaluate Skin Toxicity From Radiotherapy · NA · completed
NCT03217214 — Investigation of Contact Based Method for Diagnosis of Cardiovascular Disease · completed
NCT03094910 — Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04397380 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NHS Greater Clyde and Glasgow
Last refreshed: 22 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04397380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing